Karyopharm Therapeutics, Inc. - Wutah bathi EPS kuartalan KPTI

Logo korporat perusahaan Karyopharm Therapeutics, Inc. (KPTI)

Karyopharm Therapeutics (KPTI) relies on Massachusetts laboratories and external CDMO partners to minimize production risks. The intensity of quarterly EPS growth demonstrates profit dynamics, where the 0.00 metric serves as the target level. High authority in hematology is confirmed by the success of SINE compounds, and management is currently optimizing expenses, focusing on the most profitable developments to maintain investor confidence.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan karyopharm.com (KPTI): kanggo periode 04.07.2022 - 18.11.2026

Rincian analitis perusahaan Karyopharm Therapeutics

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:Karyopharm Therapeutics, Inc. - KPTI
Barang unggulan Karyopharm Therapeutics Inc.

The stability of the clinical base of Karyopharm Therapeutics (KPTI) in the US and EU minimizes geopolitical risks, allowing the real effectiveness of oncology drug commercialization to be assessed through the current level of quarterly EPS growth. This metric calculates the percentage change in net income per share per quarter, separating the fundamental trend from market volatility, where any negative values signal potential risks to capital.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan kymeratx.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ORIC (ORIC Pharmaceuticals Inc)|Wutah bathi resik saben saham sajroning taun lumaku Relay Pharma|Nurix Therapeutics Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Tyra Biosciences|VSTM (Verastem, Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|GLUE: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CGEM (cullinanoncology.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Immuneering Inc. IMRX|Wutah bathi EPS kuartalan CCCC|Black Diamond Therapeutics - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Repare Therapeutics Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan PMVP|PPCB: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cyclacel Pharmaceuticals - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|AADI: Wutah bathi EPS kuartalan|Aileron Therapeutics Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)